Evidence map›Paper›PMID 26671450›Full record

ArticlePloS one2015

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.

Livio Azzoni, Russell Barbour, Emmanouil Papasavvas, Deborah K Glencross, Wendy S Stevens, Mark F Cotton, Avy Violari, Luis J Montaner

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Livio AzzoniThe Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Russell BarbourBiostatistics Department, Yale School of Public Health, New Haven, Connecticut, United States of America.
Emmanouil PapasavvasThe Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Deborah K GlencrossDepartment of Molecular Medicine and Hematology, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.
Wendy S StevensDepartment of Molecular Medicine and Hematology, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.
Mark F CottonChildren's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Avy ViolariPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Luis J MontanerThe Wistar Institute, Philadelphia, Pennsylvania, United States of America.
The Wistar Institute · USUniversity of the Witwatersrand · ZANational Health Laboratory Service · ZAStellenbosch University · ZAYale University · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI E. Jennifer Edelman · 2001 to 2026
$48.5M
The effect of ART on rates and transmission of TBU19AI053217 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI VIOLARI, AVY · 2002 to 2011
$44.9M
Pediatric Immune Correlates of Early Anti-HIV TherapyR01AI062512 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J · 2005 to 2010
$3.3M
NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA10815NIAID NIH HHS AI062512NIAID NIH HHS R01 AI062512NIAID NIH HHS U19 AI053217NIAID NIH HHS U19 AI53217NIMH NIH HHS 5P30MH062294-12NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

backgroundEarly initiation of anti-retroviral treatment (ART) decreases mortality as compared to deferred treatment, but whether it preserves immune cells from early loss or promotes their recovery remains undefined. Determination of complex immunological endpoints in infants is often marred by missing data due to missed visits and/or inadequate sampling. Specialized methods are required to address missingness and facilitate data analysis.

methodsWe characterized the changes in cellular and humoral immune parameters over the first year of life in 66 HIV-infected infants (0-1 year of age) enrolled in the CHER study starting therapy within 12 weeks of birth (n = 42) or upon disease progression (n = 24). A convenience cohort of 23 uninfected infants aged 0-6 months born to mothers with HIV-1 infection was used as controls. Flow cytometry and ELISA were used to evaluate changes in natural killer (NK) cells, plasmacytoid dendritic cells (pDC), and CD4+ or CD8+ T-cell frequencies. Data missingness was assessed using Little's test. Complete datasets for analysis were created using Multiple Imputation (MI) or Bayesian modeling and multivariate analysis was conducted on the imputed datasets.

resultsHIV-1-infected infants had greater frequency of CD4+ T cells with naïve phenotype, as well as higher serum IL-7 levels than HIV exposed/uninfected infants. The elevated data missingness was completely at random, allowing the use of both MI and Bayesian modeling. Both methods indicate that early ART initiation results in higher CD4+ T cell frequency, lower expression of CD95 in CD8+ T cell, and preservation of naïve T cell subsets. In contrast, innate immune effectors appeared to be similar independently of the timing of ART initiation.

conclusionsEarly ART initiation in infants with perinatal HIV infection reduces immune activation and preserves an early expansion of naïve T-cells with undiminished innate cell numbers, giving greater immune reconstitution than achieved with deferred ART. Both statistical approaches concurred in this finding.

Indexed as

Antiretroviral Therapy, Highly ActiveDatabases as TopicBayes TheoremCD4 Lymphocyte CountCD4-Positive T-LymphocytesCohort StudiesFollow-Up StudiesHIV InfectionsHumansImmunity, InnateImmunologic MemoryInfantInterleukin-7Longitudinal StudiesLymphocyte ActivationInterleukin-7

Identifiers

PMID26671450
PMCPMC4699458
OpenAlexW2213722298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.